Terms: = Liver cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Clinical Outcome
5 results:
1. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
2. Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression.
Wang FW; Cai MY; Mai SJ; Chen JW; Bai HY; Li Y; Liao YJ; Li CP; Tian XP; Kung HF; Guan XY; Xie D
Oncotarget; 2014 Aug; 5(16):6716-33. PubMed ID: 25071013
[TBL] [Abstract] [Full Text] [Related]
3. Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.
Evert M; Frau M; Tomasi ML; Latte G; Simile MM; Seddaiu MA; Zimmermann A; Ladu S; Staniscia T; Brozzetti S; Solinas G; Dombrowski F; Feo F; Pascale RM; Calvisi DF
Br J Cancer; 2013 Nov; 109(10):2654-64. PubMed ID: 24136149
[TBL] [Abstract] [Full Text] [Related]
4. Expression of HSP70 and JNK-related proteins in human liver cancer: Potential effects on clinical outcome.
Li H; Sui C; Kong F; Zhang H; Liu J; Dong M
Dig Liver Dis; 2007 Jul; 39(7):663-70. PubMed ID: 17531560
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.
Sclabas GM; Fujioka S; Schmidt C; Li Z; Frederick WA; Yang W; Yokoi K; Evans DB; Abbruzzese JL; Hess KR; Zhang W; Fidler IJ; Chiao PJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):440-9. PubMed ID: 15701826
[TBL] [Abstract] [Full Text] [Related]
